These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 1655433)
21. Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice. Chan J; Luft BJ Antimicrob Agents Chemother; 1986 Aug; 30(2):323-4. PubMed ID: 3767344 [TBL] [Abstract][Full Text] [Related]
22. Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay. Chamberland S; Kirst HA; Current WL Antimicrob Agents Chemother; 1991 May; 35(5):903-9. PubMed ID: 1854172 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of the efficacy of prolonged administration of azithromycin in a murine model of chronic toxoplasmosis. Dumas JL; Chang R; Mermillod B; Piguet PF; Comte R; Pechère JC J Antimicrob Chemother; 1994 Jul; 34(1):111-8. PubMed ID: 7961197 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the efficacy of atovaquone alone or in combination with azithromycin against acute murine toxoplasmosis. Moshkani SK; Dalimi A Vet Res Commun; 2000 Apr; 24(3):169-77. PubMed ID: 10836275 [TBL] [Abstract][Full Text] [Related]
25. Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis. Araujo FG; Remington JS Antimicrob Agents Chemother; 1991 Aug; 35(8):1672-3. PubMed ID: 1656872 [TBL] [Abstract][Full Text] [Related]
26. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion. Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107 [TBL] [Abstract][Full Text] [Related]
27. Activity of spiramycin against Toxoplasma gondii in vitro, in experimental infections and in human infection. Chang HR; Pechère JC J Antimicrob Chemother; 1988 Jul; 22 Suppl B():87-92. PubMed ID: 3182450 [TBL] [Abstract][Full Text] [Related]
28. [Studies on the therapeutics of experimental toxoplasmosis. I. Effect of acetylspiramycin and spiramycin on the intracardiac Toxoplasma multiplication in mice infected with Toxoplasma gondii (author's transl)]. Espinas FM; Odakura Y; Suzuki N; Sasaki H Jpn J Antibiot; 1981 Aug; 34(8):1141-7. PubMed ID: 7321193 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeys. Schoondermark-Van de Ven E; Melchers W; Camps W; Eskes T; Meuwissen J; Galama J Antimicrob Agents Chemother; 1994 Sep; 38(9):1930-6. PubMed ID: 7811000 [TBL] [Abstract][Full Text] [Related]
30. Synergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in mice. Araujo FG; Lin T; Remington JS Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):71-3. PubMed ID: 1314177 [TBL] [Abstract][Full Text] [Related]
31. [The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia]. Veber B; Pocidalo JJ Pathol Biol (Paris); 1995 Jun; 43(6):524-8. PubMed ID: 8539075 [TBL] [Abstract][Full Text] [Related]
32. [In vitro effect of (+)-usnic acid on Toxoplasma gondii tachyzoites]. Wei LL; Cheng YB; Si KW; Gu N; Li XQ; Li C; Yuan YK Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):438-41. PubMed ID: 19288918 [TBL] [Abstract][Full Text] [Related]
33. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis. Derouin F; Almadany R; Chau F; Rouveix B; Pocidalo JJ Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of azithromycin in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey. Değerli K; Kilimcioğlu AA; Kurt O; Tamay AT; Ozbilgin A Acta Trop; 2003 Sep; 88(1):45-50. PubMed ID: 12943976 [TBL] [Abstract][Full Text] [Related]
35. [Investigation of combined effectiveness of spiramycin and beta-glucan in mice models of acute toxoplasmosis and determination of IL-10, IL-12 and TNF-α levels]. Büyükbaba Boral O; Sönmez Tamer G; Keçeli Özcan S; Sönmez N; Işsever H; Tekeli F Mikrobiyol Bul; 2012 Jul; 46(3):446-55. PubMed ID: 22951656 [TBL] [Abstract][Full Text] [Related]
36. Brazilian strains of Toxoplasma gondii are controlled by azithromycin and modulate cytokine production in human placental explants. Franco PS; Gois PSG; de Araújo TE; da Silva RJ; de Freitas Barbosa B; de Oliveira Gomes A; Ietta F; Dos Santos LA; Dos Santos MC; Mineo JR; Ferro EAV J Biomed Sci; 2019 Jan; 26(1):10. PubMed ID: 30665403 [TBL] [Abstract][Full Text] [Related]
37. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Araujo FG; Huskinson J; Remington JS Antimicrob Agents Chemother; 1991 Feb; 35(2):293-9. PubMed ID: 2024964 [TBL] [Abstract][Full Text] [Related]
38. [In vivo effect of dihydroartemisinin and azithromycin on the ultrastructure of Toxoplasma gondii tachyzoites]. Yin WD; Gao QC; Liu XD; Tang HW Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Aug; 27(4):325-7. PubMed ID: 20066989 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of ursolic acid derivatives with potential anti-Toxoplasma gondii activity. Zhang LH; Jin LL; Liu F; Jin C; Jin CM; Wei ZY Exp Parasitol; 2020 Sep; 216():107935. PubMed ID: 32569599 [TBL] [Abstract][Full Text] [Related]
40. [Prophylactic effects of trimethoprim-sulfamethoxazole in Toxoplasma-infected mice]. Lee YH; Lee DY; Shin DW Korean J Parasitol; 1993 Dec; 31(4):363-70. PubMed ID: 8297894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]